Case Study: Angiogenesis Inhibitors Manufacturer validates clinical trial efficacy with Quantzig patient journey analysis

How an Angiogenesis Inhibitors Manufacturer Validated the Efficacy of their Clinical Trials

Quantzig worked with Angiogenesis Inhibitors Manufacturer, a U.S.-based healthcare company and leading maker of angiogenesis inhibitor drugs, to address a key challenge: gaining a 360° view of the cancer patient journey and validating how well clinical trial outcomes translated to real-world settings. The customer wanted to compare drug performance in everyday care versus ideal clinical conditions, using patient journey analysis and real-world data.

Quantzig implemented a patient journey analysis engagement that mapped treatment paths using hospital admission data, pharmacy records, lab results, progress notes, and discharge summaries. As a result, the client created a validation framework to assess clinical trial effectiveness against real-world evidence and gained actionable insights into drug performance outside the trial environment.